Skip to main content

Table 1 Demographic and clinical data of the investigated case-parent trio, the extended family, and the unrelated healthy control individual

From: Investigation of de novo mutations in a schizophrenia case-parent trio by induced pluripotent stem cell-based in vitro disease modeling: convergence of schizophrenia- and autism-related cellular phenotypes

Subject

Sex

Age

Medical history

Code

Father

M

59

No psychiatric treatment or other major somatic disorders.

iPSC-SZ-HU-FA 1

Mother

F

55

No psychiatric treatment or other major somatic disorders.

iPSC-SZ-HU-MO 1 and 2

Proband (son)

M

24

Diagnosed with schizophrenia at the age of 17. During the past 10 years had 3 hospitalizations, receives clozapine treatment. Predominantly negative symptoms, as measured by PANSS.

iPSC-SZ-HU-PROB 1 and 2

Unaffected older sibling

M

28

No psychiatric treatment or other major somatic disorders.

Younger sibling

F

21

Diagnosed with bipolar affective disorder at age of 18 after suicidal attempt. Receives lithium and olanzapine treatment.